Cannabinoids orchestrate cross-talk between cancer cells and endothelial cells in colorectal cancer
- 18 May 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in Cancer Gene Therapy
- Vol. 29 (5), 597-611
- https://doi.org/10.1038/s41417-021-00346-0
Abstract
Medical marijuana has been approved by the FDA for treating chemotherapy-induced nausea and vomiting. However, less is known about its direct effects on tumor cells and the tumor microenvironment. In this study, RNA-sequencing datasets in the NCBI GEO repository were first analyzed; upregulation of cannabinoid receptors was observed in both primary and metastatic colorectal cancer (CRC) tumor tissues. An increase of cannabinoid receptors was also found in patients with CRC, azoxymethane/dextran sulfate sodium-induced CRC and CRC metastatic mouse models. Δ9-Tetrahydrocannabinol (Δ9-THC)-induced tumor progression in both primary and metastatic mouse models and also increased angiogenesis. A human growth factor antibody array indicated that Δ9-THC promoted the secretion of angiogenic growth factors in CRC, leading to the induction of tube formation and migration in human-induced pluripotent stem cell-derived vascular endothelial cells. The nuclear translocation of STAT1 played important roles in Δ9-THC-induced angiogenesis and tumor progression. Pharmacological treatment with STAT1 antagonist or abrogation of STAT1 with CRISPR/Cas9-based strategy rescued those effects of Δ9-THC in CRC. This study demonstrates that marijuana might increase the risk of CRC progression and that inhibition of STAT1 is a potential strategy for attenuating these side effects.Keywords
Funding Information
- Ministry of Science and Technology, Taiwan (MOST108-2636-B-002-007, MOST109-2636-B-002-007)
This publication has 80 references indexed in Scilit:
- A systematic review of treatment guidelines for metastatic colorectal cancerColorectal Disease, 2011
- Cancer Cachexia: Mechanisms and Clinical ImplicationsGastroenterology Research and Practice, 2011
- Molecular, cellular and physiological characterization of the cancer cachexia-inducing C26 colon carcinoma in mouseBMC Cancer, 2010
- Species differences in cannabinoid receptor 2 (CNR2 gene): identification of novel human and rodent CB2 isoforms, differential tissue expression and regulation by cannabinoid receptor ligandsGenes, Brain and Behavior, 2009
- A high cannabinoid CB1 receptor immunoreactivity is associated with disease severity and outcome in prostate cancerEuropean Journal of Cancer, 2009
- Induced Pluripotent Stem Cell Lines Derived from Human Somatic CellsScience, 2007
- Orthotopic Mouse Model of Colorectal CancerJournal of Visualized Experiments, 2007
- Cannabinoids in pancreatic cancer: Correlation with survival and painInternational Journal of Cancer, 2007
- DAVID Bioinformatics Resources: expanded annotation database and novel algorithms to better extract biology from large gene listsNucleic Acids Research, 2007
- ApcMin: A mouse model for intestinal and mammary tumorigenesisEuropean Journal of Cancer, 1995